How PT-141 treatments work here Three steps
The page is research-only and does not provide dosing, clinical, diagnostic, veterinary, or human-use guidance
In adults with type 2 diabetes, doses up to 12 mg weekly produced roughly 17% weight loss at 36 weeks alongside ~2.0% HbA1c reductions versus placebo [3]
Whilst the early evidence for retatrutide liver fat reduction is scientifically promising, patients are best served by working within established NHS pathways and awaiting the outcome of robust Phase 3 trial data and formal regulatory review before drawing firm conclusions about this emerging therapy
Pregnancy, Breastfeeding, and Fertility Retatrutide is absolutely contraindicated during pregnancy
Research suggests cycles of up to 12 weeks with breaks in between to maintain efficacy and prevent tolerance